P
PLX//CIK 0001006281
Protalix BioTherapeutics, Inc.
Market Data
$2.54+$0.21 (+9.01%)
PLX · Last trade
Prev Close
$2.33
Range (30d)
$2.22 – $2.62
Recent Filings
- 10-Q4.6 MBProtalix BioTherapeutics, Inc.Aug 12, 7:09 AM ET·0001104659-26-094444
- 8-K394.4 KBProtalix BioTherapeutics, Inc.Aug 12, 6:59 AM ET·0001104659-26-094433
- SCHEDULE 13G11.0 KBProtalix BioTherapeutics, Inc.Jul 29, 3:19 PM ET·0002012383-26-002863
- 8-K380.1 KBProtalix BioTherapeutics, Inc.Jun 25, 4:30 PM ET·0001104659-26-077790
- 8-K4.6 MBProtalix BioTherapeutics, Inc.May 21, 7:03 AM ET·0001104659-26-064850
- 10-Q3.7 MBProtalix BioTherapeutics, Inc.May 13, 7:06 AM ET·0001104659-26-059756
- 8-K373.7 KBProtalix BioTherapeutics, Inc.May 13, 6:57 AM ET·0001104659-26-059749
- 10-K11.6 MBProtalix BioTherapeutics, Inc.Mar 18, 7:12 AM ET·0001104659-26-029858
- 8-K393.2 KBProtalix BioTherapeutics, Inc.Mar 18, 6:56 AM ET·0001104659-26-029846
- 8-K229.4 KBProtalix BioTherapeutics, Inc.Mar 9, 7:51 AM ET·0001104659-26-024975
Insiders
10- Akirov AlfredDirector
- Almon Einat BrillSVP, Chief Development Officer
- Aviezer DavidDirector, President & CEO
- Bar-Shalev AmosDirector
- Bashan DrorDirector, PRESIDENT AND CEO
- Ben Zvi ShmuelDirector
- Boudes Pol FDirector
- Bronfeld ZeevDirector
- Camber Capital Management LP10% Owner
- Dexcel Pharma Technologies Ltd.10% Owner
Tickers
Addresses
business
2 UNIVERSITY PLAZA SUITE 100
HACKENSACK, NJ, 07601
mailing
2 UNIVERSITY PLAZA SUITE 100
HACKENSACK, NJ, 07601
Former Names
- ORTHODONTIX INC2007-02-22
- EMBASSY ACQUISITION CORP1998-03-31